Impact of a health literacy intervention combining general practitioner training and a consumer facing intervention to improve colorectal cancer screening in underserved areas: protocol for a multicentric cluster randomized controlled trial

Marie-Anne Durand, Aurore Lamouroux, Niamh M Redmond, Michel Rotily, Aurélie Bourmaud, Anne-Marie Schott, Isabelle Auger-Aubin, Adèle Frachon, Catherine Exbrayat, Christian Balamou, Laëtitia Gimenez, Pascale Grosclaude, Nora Moumjid, Julie Haesebaert, Helene Delattre Massy, Julia Bardes, Rajae Touzani, Laury Beaubrun En Famille Diant, Clémence Casanova, Jean François Seitz, Julien Mancini, Cyrille Delpierre, Marie-Anne Durand, Aurore Lamouroux, Niamh M Redmond, Michel Rotily, Aurélie Bourmaud, Anne-Marie Schott, Isabelle Auger-Aubin, Adèle Frachon, Catherine Exbrayat, Christian Balamou, Laëtitia Gimenez, Pascale Grosclaude, Nora Moumjid, Julie Haesebaert, Helene Delattre Massy, Julia Bardes, Rajae Touzani, Laury Beaubrun En Famille Diant, Clémence Casanova, Jean François Seitz, Julien Mancini, Cyrille Delpierre

Abstract

Background: Colorectal cancer (CRC) is a leading cause of cancer burden worldwide. In France, it is the second most common cause of cancer death after lung cancer. Systematic uptake of CRC screening can improve survival rates. However, people with limited health literacy (HL) and lower socioeconomic position rarely participate. Our aim is to assess the impact of an intervention combining HL and CRC screening training for general practitioners (GPs) with a pictorial brochure and video targeting eligible patients, to increase CRC screening and other secondary outcomes, after 1 year, in several underserved geographic areas in France.

Methods: We will use a two-arm multicentric randomized controlled cluster trial with 32 GPs primarily serving underserved populations across four regions in France with 1024 patients recruited. GPs practicing in underserved areas (identified using the European Deprivation Index) will be block-randomized to: 1) a combined intervention (HL and CRC training + brochure and video for eligible patients), or 2) usual care. Patients will be included if they are between 50 and 74 years old, eligible for CRC screening, and present to recruited GPs. The primary outcome is CRC screening uptake after 1 year. Secondary outcomes include increasing knowledge and patient activation. After trial recruitment, we will conduct semi-structured interviews with up to 24 GPs (up to 8 in each region) and up to 48 patients (6 to 12 per region) based on data saturation. We will explore strategies that promote the intervention's sustained use and rapid implementation using Normalization Process Theory. We will follow a community-based participatory research approach throughout the trial. For the analyses, we will adopt a regression framework for all quantitative data. We will also use exploratory mediation analyses. We will analyze all qualitative data using a framework analysis guided by Normalization Process Theory.

Discussion: Limited HL and its impact on the general population is a growing public health and policy challenge worldwide. It has received limited attention in France. A combined HL intervention could reduce disparities in CRC screening, increase screening rates among the most vulnerable populations, and increase knowledge and activation (beneficial in the context of repeated screening).

Trial registration: Registry: ClinicalTrials.gov.

Trial registration number: 2020-A01687-32 . Date of registration: 17th November 2020.

Trial registration: ClinicalTrials.gov NCT04631692.

Keywords: Colorectal cancer screening; General practitioner training, health disparities; Health literacy; Intervention.

Conflict of interest statement

Marie-Anne Durand has contributed to the development of Option Grid patient decision aids (from which Picture Option Grid is derived). EBSCO Information Services sells subscription access to Option Grid patient decision aids. She receives consulting income from EBSCO Health, and royalties. No other competing interests declared.

© 2021. The Author(s).

Figures

Fig. 1
Fig. 1
Logic model of the intervention and study. Legend: TRAPD: Translation, Review, Adjudication, Pretest, Documentation
Fig. 2
Fig. 2
Causal model for patients enrolled in the trial. Legend: Arrows depicted in green (solid line), red (long-dashed line) and blue (short-dashed line) represent causal relationships of one variable on another. The presence of green arrows will be examined in hypothesis 1. The presence of blue arrows (mediation effects) and red arrows (moderation effects) will be examined in an exploratory analysis
Fig. 3
Fig. 3
CONSORT flow diagram

References

    1. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–86. 10.1002/ijc.29210. Epub 2014 Oct 9.
    1. Kobayashi LC, Wardle J, von Wagner C. Limited health literacy is a barrier to colorectal cancer screening in England: evidence from the English Longitudinal Study Of Ageing. Prev Med. 2014;61:100–105. doi: 10.1016/j.ypmed.2013.11.012.
    1. Arnold M, Sierra MS, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global patterns and trends in colorectal cancer incidence and mortality. Gut. 2017;66(4):683–691. doi: 10.1136/gutjnl-2015-310912.
    1. Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, Schuman LM, Ederer F. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med. 1993;328(19):1365–1371. doi: 10.1056/NEJM199305133281901.
    1. Mandel JS, Church TR, Bond JH, Ederer F, Geisser MS, Mongin SJ, Snover DC, Schuman LM. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med. 2000;343(22):1603–1607. doi: 10.1056/NEJM200011303432203.
    1. Moss S, Ancelle-Park R, Brenner H; International Agency for Research on Cancer. European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition--Evaluation and interpretation of screening outcomes. Endoscopy. 2012;44 Suppl 3:SE49-64. 10.1055/s-0032-1309788. Epub 2012 Sep 25.
    1. Gimeno Garcia AZ. Factors influencing colorectal cancer screening participation. Gastroenterol Res Pract. 2012;2012:483417. doi: 10.1155/2012/483417.
    1. Pornet C, Dejardin O, Morlais F, Bouvier V, Launoy G. Socioeconomic determinants for compliance to colorectal cancer screening. A multilevel analysis. J Epidemiol Community Health. 2010;64(4):318–324. doi: 10.1136/jech.2008.081117.
    1. Cancer INd . In: Les cancers en France: L’essentiel des faits et chiffres/Edition 2019. , editor. 2019.
    1. Santé Publique France 2020; 2021. Webpage: . Accessed 23 Feb 2021.
    1. Pornet C, Dejardin O, Morlais F, Bouvier V, Launoy G. Socioeconomic and healthcare supply statistical determinants of compliance to mammography screening programs: a multilevel analysis in Calvados, France. Cancer Epidemiol. 2010;34(3):309–315. doi: 10.1016/j.canep.2010.03.010.
    1. Mackenbach JP, Stirbu I, Roskam AJ, Schaap MM, Menvielle G, Leinsalu M, et al. Socioeconomic inequalities in health in 22 European countries. N Engl J Med. 2008;358(23):2468–2481. doi: 10.1056/NEJMsa0707519.
    1. Menvielle G, Kunst A. Social inequalities in cancer incidence and cancer survival: lessons from Danish studies. Eur J Cancer. 2008;44(14):1933–1937. doi: 10.1016/j.ejca.2008.06.034.
    1. Menvielle G, Kunst AE, Stirbu I, Strand BH, Borrell C, Regidor E, Leclerc A, Esnaola S, Bopp M, Lundberg O, Artnik B, Costa G, Deboosere P, Martikainen P, Mackenbach JP. Educational differences in cancer mortality among women and men: a gender pattern that differs across Europe. Br J Cancer. 2008;98(5):1012–1019. doi: 10.1038/sj.bjc.6604274.
    1. Ratzan SC, Parker RM. Introduction. In: Selden CR, Zorn M, Ratzan SC, Parker RM, editors. National Library of medicine current bibliographies in medicine: health literacy. Bethesda: National Institutes of Health, U.S. Department of Health and Human Servies; 2000.
    1. Nutbeam D. Building health literacy in Australia. Med J Aust. 2009;191(10):525–526. doi: 10.5694/j.1326-5377.2009.tb03301.x.
    1. Nutbeam D, McGill B, Premkumar P. Improving health literacy in community populations: a review of progress. Health Promot Int. 2018;33(5):901–911. doi: 10.1093/heapro/dax015.
    1. Sorensen K, Brand H. Health literacy-a strategic asset for corporate social responsibility in Europe. J Health Commun. 2011;16(Suppl 3):322–7. 10.1080/10810730.2011.606072.
    1. Sorensen K, Pelikan JM, Rothlin F, Ganahl K, Slonska Z, Doyle G, et al. Health literacy in Europe: comparative results of the European health literacy survey (HLS-EU) Eur J Pub Health. 2015;25(6):1053–1058. doi: 10.1093/eurpub/ckv043.
    1. Sorensen K, Van den Broucke S, Fullam J, Doyle G, Pelikan J, Slonska Z, et al. Health literacy and public health: a systematic review and integration of definitions and models. BMC Public Health. 2012;12(1):80. doi: 10.1186/1471-2458-12-80.
    1. Berkman ND, Dewalt DA, Pignone MP, Sheridan SL, Lohr KN, Lux L, Sutton SF, Swinson T, Bonito AJ. Literacy and health outcomes. Evid Rep Technol Assess (Summ). 2004;87:1–8.
    1. Berkman ND, Sheridan SL, Donahue KE, Halpern DJ, Crotty K. Low health literacy and health outcomes: an updated systematic review. Ann Intern Med. 2011;155(2):97–107. doi: 10.7326/0003-4819-155-2-201107190-00005.
    1. Berkman ND, Sheridan SL, Donahue KE, Halpern DJ, Viera A, Crotty K, Holland A, Brasure M, Lohr KN, Harden E, Tant E, Wallace I, Viswanathan M. Health literacy interventions and outcomes: an updated systematic review. Evid Rep Technol Assess (Full Rep). 2011;199:1–941.
    1. Dewalt DA, Berkman ND, Sheridan S, Lohr KN, Pignone MP. Literacy and health outcomes: a systematic review of the literature. J Gen Intern Med. 2004;19(12):1228–1239. doi: 10.1111/j.1525-1497.2004.40153.x.
    1. Bostock S, Steptoe A. Association between low functional health literacy and mortality in older adults: longitudinal cohort study. BMJ. 2012;344(mar15 3):e1602. doi: 10.1136/bmj.e1602.
    1. Bennett IM, Chen J, Soroui JS, White S. The contribution of health literacy to disparities in self-rated health status and preventive health behaviors in older adults. Ann Fam Med. 2009;7(3):204–211. doi: 10.1370/afm.940.
    1. Oldach BR, Katz ML. Health literacy and cancer screening: a systematic review. Patient Educ Couns. 2014;94(2):149–157. doi: 10.1016/j.pec.2013.10.001.
    1. Peterson NB, Dwyer KA, Mulvaney SA, Dietrich MS, Rothman RL. The influence of health literacy on colorectal cancer screening knowledge, beliefs and behavior. J Natl Med Assoc. 2007;99(10):1105–1112.
    1. Miller DP, Jr, Brownlee CD, McCoy TP, Pignone MP. The effect of health literacy on knowledge and receipt of colorectal cancer screening: a survey study. BMC Fam Pract. 2007;8(1):16. doi: 10.1186/1471-2296-8-16.
    1. Davis TC, Dolan NC, Ferreira MR, Tomori C, Green KW, Sipler AM, Bennett CL. The role of inadequate health literacy skills in colorectal cancer screening. Cancer Investig. 2001;19(2):193–200. doi: 10.1081/CNV-100000154.
    1. von Wagner C, Semmler C, Good A, Wardle J. Health literacy and self-efficacy for participating in colorectal cancer screening: the role of information processing. Patient Educ Couns. 2009;75(3):352–357. doi: 10.1016/j.pec.2009.03.015.
    1. Lloyd JE, Song HJ, Dennis SM, Dunbar N, Harris E, Harris MF. A paucity of strategies for developing health literate organisations: a systematic review. PLoS One. 2018;13(4):e0195018. doi: 10.1371/journal.pone.0195018.
    1. Ferreira MR, Dolan NC, Fitzgibbon ML, Davis TC, Gorby N, Ladewski L, Liu D, Rademaker AW, Medio F, Schmitt BP, Bennett CL. Health care provider-directed intervention to increase colorectal cancer screening among veterans: results of a randomized controlled trial. J Clin Oncol. 2005;23(7):1548–1554. doi: 10.1200/JCO.2005.07.049.
    1. Schulz KF, Altman DG, Moher D, Group C CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340(mar23 1):c332. doi: 10.1136/bmj.c332.
    1. Chan AW, Tetzlaff JM, Altman DG, Laupacis A, Gotzsche PC, Krleza-Jeric K, et al. SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med. 2013;158(3):200–207. doi: 10.7326/0003-4819-158-3-201302050-00583.
    1. Pornet C, Delpierre C, Dejardin O, Grosclaude P, Launay L, Guittet L, Lang T, Launoy G. Construction of an adaptable European transnational ecological deprivation index: the French version. J Epidemiol Community Health. 2012;66(11):982–989. doi: 10.1136/jech-2011-200311.
    1. Grande SW, Durand MA, Fisher ES, Elwyn G. Physicians as part of the solution? Community-based participatory research as a way to get shared decision making into practice. J Gen Intern Med. 2014;29(1):219–222. doi: 10.1007/s11606-013-2602-2.
    1. Israel BA, Coombe CM, Cheezum RR, Schulz AJ, McGranaghan RJ, Lichtenstein R, et al. Community-based participatory research: a capacity-building approach for policy advocacy aimed at eliminating health disparities. Am J Public Health. 2010;100(11):2094–2102. doi: 10.2105/AJPH.2009.170506.
    1. Wallerstein NB, Duran B. Using community-based participatory research to address health disparities. Health Promot Pract. 2006;7(3):312–323. doi: 10.1177/1524839906289376.
    1. Cooper LA, Hill MN, Powe NR. Designing and evaluating interventions to eliminate racial and ethnic disparities in health care. J Gen Intern Med. 2002;17(6):477–486. doi: 10.1046/j.1525-1497.2002.10633.x.
    1. Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Petticrew M. Developing and evaluating complex interventions: the new Medical Research Council guidance. Bmj. 2008;337:a1655. doi: 10.1136/bmj.a1655.
    1. Mengoni SE, Gates B, Parkes G, Wellsted D, Barton G, Ring H, Khoo ME, Monji-Patel D, Friedli K, Zia A, Irvine L, Durand MA. Wordless intervention for people with epilepsy and learning disabilities (WIELD): a randomised controlled feasibility trial. BMJ Open. 2016;6(11):e012993. doi: 10.1136/bmjopen-2016-012993.
    1. Hibbard JH, Stockard J, Mahoney ER, Tusler M. Development of the Patient Activation Measure (PAM): conceptualizing and measuring activation in patients and consumers. Health Serv Res. 2004;39(4 Pt 1):1005–26.
    1. Hibbard JH ME, Stockard J, Tusler M,. Development and testing of a short form of the patient activation measure. Health Serv Res. 2005;40(6):1918–30.
    1. Mansfield ED WR, Gillis DE, Weiss BD, L'Abbé M. Canadian adaptation of the Newest Vital Sign©, a health literacy assessment tool. Public Health Nutr. 2018;21(11):2038–45.
    1. Chew LD, Griffin JM, Partin MR, et al. Validation of screening questions for limited health literacy in a large VA outpatient population. J Gen Intern Med. 2008;23(5):561–6. 10.1007/s11606-008-0520-5. Epub 2008 Mar 12.
    1. Legare F, Kearing S, Clay K, et al. Are you SURE?: Assessing patient decisional conflict with a 4-item screening test. Can Fam Physician. 2010;56(8):e308-14.
    1. Farrin ARI, Torgerson D, Underwood M, UK BEAM Trial Team Differential recruitment in a cluster randomized trial in primary care: the experience of the UK back pain, exercise, active management and manipulation (UK BEAM) feasibility study. Clin Trials. 2005;2(2):119–124. doi: 10.1191/1740774505cn073oa.
    1. Eldridge SAD, Bennett C, Wakelin M, Feder G. Internal and external validity of cluster randomised trials: systematic review of recent trials. BMJ. 2008;336(7649):876–880. doi: 10.1136/bmj.39517.495764.25.
    1. May C, Finch T, Mair F, Ballini L, Dowrick C, Eccles M, Gask L, MacFarlane A, Murray E, Rapley T, Rogers A, Treweek S, Wallace P, Anderson G, Burns J, Heaven B. Understanding the implementation of complex interventions in health care: the normalization process model. BMC Health Serv Res. 2007;7(1):148. doi: 10.1186/1472-6963-7-148.
    1. Scalia P, Elwyn G, Durand MA. “Provoking conversations”: case studies of organizations where Option Grid decision aids have become ‘normalized’. BMC Med Inform Decis Mak. 2017;17(1):124. doi: 10.1186/s12911-017-0517-2.
    1. Durand MA, Yen RW, O'Malley AJ, Politi MC, Dhage S, Rosenkranz K, et al. What matters most: protocol for a randomized controlled trial of breast cancer surgery encounter decision aids across socioeconomic strata. BMC Public Health. 2018;18(1):241. doi: 10.1186/s12889-018-5109-2.
    1. Raudenbush SW, Bryk AS. Hierarchical Linear Models: Applications and Data Analysis Methods (Advanced Quantitative Techniques in the Social Sciences). London: SAGE Publications; 2001.
    1. Liang KYZS-L. Longitudinal data analysis using generalized linear models. Biometrika. 1986;73(1):13–22. doi: 10.1093/biomet/73.1.13.
    1. Zeger SL, Liang KY. Longitudinal data analysis for discrete and continuous outcomes. Biometrics. 1986;42(1):121–130. doi: 10.2307/2531248.
    1. Carey G, Crammond B, De Leeuw E. Towards health equity: a framework for the application of proportionate universalism. Int J Equity Health. 2015;14(1):81. doi: 10.1186/s12939-015-0207-6.

Source: PubMed

3
Abonnieren